Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1

Table 1

Primers used in this study.

Target	Forward	Reverse
Mice-GAPDH	TCATCAACGGGAAGCCCATC	CTCGTGGTTCACACCCATCA
Mice-ANP	ACCTGCTAGACCACCTGGAG	CCTTGGCTGTTATCTTCGGTACCGG
Mice-BNP	GAGGTCACTCCTATCCTCTGG	GCCATTTCCTCCGACTTTTCTC
Mice-fibronectin	CCGGTGGCTGTCAGTCAGA	CCGTTCCCACTGCTGATTTATC
Mice-CTGF	TGTGTGATGAGCCCAAGGAC	AGTTGGCTCGCATCATAGTTG
Mice-IL1β	TGGTACATCAGCCCGAAC	GTCAGCTGGATAGCGACA
Mice-IL6	GTCAGCTGGATAGCGACA	GAAGCACAGGAGCAGGT GTAGA
NQO1	GGTGAGCTGAAGGACTCGAA	CAATATCTGGGCTCAGGCGT
Mice-TNFα	GACATGCCGCCTGGAGAAAC	AGCCCAGGATGCCCTTTAGT
SOD1	GGAACCATCCACTTCGAGCA	CCCATGCTGGCCTTCAGTTA
SOD2	GAACAATCTCAACGCCACCG	GCTGAAGAGCGACCTGAGTT
Rat-GAPDH	ACTCCACTCACGGCAAATTC	TCTCCATGGTGGTGAAGACA
Rat-IL1β	CCGTGGACCTTCCAGGATGA	GGGAACGTCACACACCAGCA
Rat-IL6	AGTTGCCTTCTTGGGACTGA	TCCACGATTTCCCAGAGAAC
Rat-TNFα	CATCTTCTCAAAATTCGAGTGACAA	TGGGAGTAGACAAGGTACAACCC